Company Filing History:
11 out of 164 
4 out of 2,113 
3 out of 1,164 
Years Active: 1997-2005
Title: The Innovative Contributions of Kate Loughney
Introduction
Kate Loughney is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of biotechnology, holding a total of 12 patents. Her work focuses on novel polypeptides and methods that have the potential to advance medical science.
Latest Patents
Among her latest patents is the invention related to Phosphodiesterase 10. This invention provides novel human PDE10 polypeptides, polynucleotides encoding these polypeptides, and methods for producing PDE10 polypeptides. Additionally, it includes antisense polynucleotides and antibodies that are specifically immunoreactive with the PDE10 polypeptides. Another significant patent is the ATR-2 cell cycle checkpoint, which discloses polynucleotides encoding novel Atr-2 cell cycle checkpoint polypeptides, along with methods to produce these polypeptides using transformed host cells.
Career Highlights
Kate has worked with notable organizations such as Icos Corporation and the University of Washington. Her experience in these institutions has allowed her to develop and refine her innovative ideas, contributing to her success as an inventor.
Collaborations
Throughout her career, Kate has collaborated with esteemed colleagues, including Joseph A Beavo and Jackie D Corbin. These partnerships have further enriched her research and development efforts.
Conclusion
Kate Loughney's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her innovative work continues to pave the way for advancements in medical science.